BioMarin Pharma News, BioMarin Pharma Quote, BMRN Quote

BioMarin Pharma (NQ:BMRN) Delayed: 58.98 -0.13 (0.22%)

Prev. Close

$59.11

Today 6M 1Y 5Y

Open

$58.96

52 Wk High

$108.96

52 Wk Low

$62.12

Day High

$59.71

Day Low

$58.26

P/E

N/A

EPS

$-1.27

Volume

764,678

Friends, Peers and Foes (?): ALNY, REGN, IONS, VRTX, FOLD (more...)

ALERTS | RSS

Jul 16, 2026 05:03 AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $76 at Citi
Jul 14, 2026 06:57 AM H.C. Wainwright Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
Jul 13, 2026 04:15 PM BioMarin completes acquisition of Amicus Therapeutics
Jul 13, 2026 04:07 PM Form 8-K/A BIOMARIN PHARMACEUTICAL For: Apr 27
Jul 13, 2026 09:05 AM FDA accepts BioMarin's application for full approval of achondroplasia drug
Jul 13, 2026 09:05 AM U.S. Food and Drug Administration Accepts BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Children With Achondroplasia
Jul 7, 2026 07:59 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $62 at RBC Capital
Jun 22, 2026 09:25 AM Stifel Reiterates Hold Rating on BioMarin Pharmaceutical Inc. (BMRN)
Jun 22, 2026 06:58 AM H.C. Wainwright Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
Jun 16, 2026 09:05 AM BioMarin shares VOXZOGO three-year data and BMN 333 Phase 1 results

Entities mentioned with BMRN

View All Entities